The manufacturer of the antipsychotic Zyprexa, Eli Lilly knew about the dangers of the drug since 1998. Zyprexa, or olanzapine, treats schizophrenia and bipolar disorder, or manic depression. It is the worlds fifth-bestselling drug and has been linked to an increase in diabetes.